Transforming growth factor b1 (TGF-b1) belongs to a family of multifunctional modulatory proteins involved in cell growth, differentiation, development, and wound healing. Although the biological activities of TGF-b1 have been extensively studied, its regulation remains obscure. Here we report the e
Inhibition of hepatic transcriptional induction of lipopolysaccharide-binding protein by transforming-growth-factor β1
✍ Scribed by Werner Hallatschek; Gesa Fiedler; Carsten J. Kirschning; Fränzi Creutzburg; Norbert Lamping; Andreas Nüssler; Ralf R. Schumann
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 281 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract TGF‐β (transforming growth factor‐beta) plays a key role in osteoblast differentiation and bone development. While the ability of TGF‐β to inhibit the expression of osteoblast differentiation genes has been well documented, the mechanism of this inhibition is not yet completely characte
Microglia are one of the major glial cell types within the central nervous system, and can function as immune effector cells upon activation. CD40 is a cell surface receptor belonging to the TNF receptor family that plays a critical role in the regulation of immune responses. In this study, we inves
## Abstract PTEN is a critical tumor suppressor gene mutated frequently in various human cancers. Previous studies have showed that PTEN mRNA expression is down‐regulated by TGF‐β1 in various cell lines. In present study, we have found that TGF‐β1 down‐regulates PTEN mRNA and protein expression in
## Abstract Insulin‐like growth factor binding protein‐3 (IGFBP‐3) has been proposed to mediate the growth inhibitory effects of transforming growth factor (TGF)‐β in breast and prostate cancer cells. Both TGF‐β and exogenous IGFBP‐3 inhibit DNA synthesis in Mv1 mink lung epithelial cells (CCL64).
## BACKGROUND. To study the possible relationship between adrenergic activities and the pathogenesis of benign prostatic hyperplasia (BPH), we tested the effect of doxazosin, an ␣1-adrenoceptor antagonist, on prostatic growth in vivo using a mouse model for BPH. METHODS. The mouse prostate reconst